IKT
Inhibikase Therapeutics Inc
1.90$
-2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 8.3% | 656,800.0% | – | – | – | 25.0% | – | – | – | – | – | – | – | |
| 91.7% | -656,700.0% | – | – | – | -25.0% | – | – | – | – | – | – | – | |
| 4,053.8% | 300,298,000.0% | – | – | – | 27,354.0% | – | – | – | – | – | – | – | |
| 2,039.6% | 140,058,700.0% | – | – | – | 21,828.2% | – | – | – | – | – | – | – | |
| 6,085.1% | 439,699,900.0% | – | – | – | 49,182.2% | – | – | – | – | – | – | – | |
| -5,993.4% | -440,356,600.0% | – | – | – | -49,207.2% | – | – | – | – | – | – | – | |
| 70.3% | 66,160,600.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -5,775.1% | -417,794,000.0% | – | – | – | -46,177.1% | – | – | – | – | – | – | – | |
| 58.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -5,775.1% | -417,794,000.0% | – | – | – | -46,177.1% | – | – | – | – | – | – | – | |
| -5,766.9% | -417,137,200.0% | – | – | – | -46,152.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.